Non-invasive Aesthetic Treatment Market (By Procedure Type: Injectables, Skin Rejuvenation; By End-use: Hospital/Surgery Center, Medspa, Traditional Spa, HCP owned clinic) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Non-invasive Aesthetic Treatment Market, By Procedure Type

7.1.  Non-invasive Aesthetic Treatment Market, by Procedure Type, 2021-2030

7.1.1.    Injectables

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Skin Rejuvenation

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Non-invasive Aesthetic Treatment Market, By End-use

8.1.  Non-invasive Aesthetic Treatment Market, by End-use, 2021-2030

8.1.1.    Hospital/Surgery Center

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Medspa

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Traditional Spa

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    HCP owned clinic

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Non-invasive Aesthetic Treatment Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by End-use (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by End-use (2017-2030)

Chapter 10.  Company Profiles

10.1.              Hologic, Inc.

10.1.1.  Company Overview

10.1.2.  Procedure Type Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Allergan, Inc.

10.2.1.  Company Overview

10.2.2.  Procedure Type Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Galderma S.A

10.3.1.  Company Overview

10.3.2.  Procedure Type Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Alma Lasers

10.4.1.  Company Overview

10.4.2.  Procedure Type Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Syneron Candela

10.5.1.  Company Overview

10.5.2.  Procedure Type Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Johnson & Johnson

10.6.1.  Company Overview

10.6.2.  Procedure Type Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              MerzPharma

10.7.1.  Company Overview

10.7.2.  Procedure Type Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Lumenis

10.8.1.  Company Overview

10.8.2.  Procedure Type Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Solta

10.9.1.  Company Overview

10.9.2.  Procedure Type Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Cutera Inc.

10.10.1.               Company Overview

10.10.2.               Procedure Type Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms